564 related articles for article (PubMed ID: 26206376)
1. Ex vivo immunosuppressive effects of mesenchymal stem cells on Crohn's disease mucosal T cells are largely dependent on indoleamine 2,3-dioxygenase activity and cell-cell contact.
Ciccocioppo R; Cangemi GC; Kruzliak P; Gallia A; Betti E; Badulli C; Martinetti M; Cervio M; Pecci A; Bozzi V; Dionigi P; Visai L; Gurrado A; Alvisi C; Picone C; Monti M; Bernardo ME; Gobbi P; Corazza GR
Stem Cell Res Ther; 2015 Jul; 6(1):137. PubMed ID: 26206376
[TBL] [Abstract][Full Text] [Related]
2. Indoleamine 2,3-dioxygenase mediates inhibition of virus-specific CD8(+) T cell proliferation by human mesenchymal stromal cells.
Hong J; Hueckelhoven A; Wang L; Schmitt A; Wuchter P; Tabarkiewicz J; Kleist C; Bieback K; Ho AD; Schmitt M
Cytotherapy; 2016 May; 18(5):621-9. PubMed ID: 27008974
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal Stromal Cells Derived From Crohn's Patients Deploy Indoleamine 2,3-dioxygenase-mediated Immune Suppression, Independent of Autophagy.
Chinnadurai R; Copland IB; Ng S; Garcia M; Prasad M; Arafat D; Gibson G; Kugathasan S; Galipeau J
Mol Ther; 2015 Jul; 23(7):1248-1261. PubMed ID: 25899824
[TBL] [Abstract][Full Text] [Related]
4. Human mesenchymal stromal cells transiently increase cytokine production by activated T cells before suppressing T-cell proliferation: effect of interferon-γ and tumor necrosis factor-α stimulation.
Cuerquis J; Romieu-Mourez R; François M; Routy JP; Young YK; Zhao J; Eliopoulos N
Cytotherapy; 2014 Feb; 16(2):191-202. PubMed ID: 24438900
[TBL] [Abstract][Full Text] [Related]
5. Interferon-γ regulates the function of mesenchymal stem cells from oral lichen planus via indoleamine 2,3-dioxygenase activity.
Zhang Z; Han Y; Song J; Luo R; Jin X; Mu D; Su S; Ji X; Ren YF; Liu H
J Oral Pathol Med; 2015 Jan; 44(1):15-27. PubMed ID: 25212102
[TBL] [Abstract][Full Text] [Related]
6. Tolerogenic effect of mesenchymal stromal cells on gliadin-specific T lymphocytes in celiac disease.
Ciccocioppo R; Camarca A; Cangemi GC; Radano G; Vitale S; Betti E; Ferrari D; Visai L; Strada E; Badulli C; Locatelli F; Klersy C; Gianfrani C; Corazza GR
Cytotherapy; 2014 Aug; 16(8):1080-91. PubMed ID: 24831843
[TBL] [Abstract][Full Text] [Related]
7. Induction of indoleamine-2,3 dioxygenase in bone marrow stromal cells inhibits myeloma cell growth.
Pfeifer S; Schreder M; Bolomsky A; Graffi S; Fuchs D; Sahota SS; Ludwig H; Zojer N
J Cancer Res Clin Oncol; 2012 Nov; 138(11):1821-30. PubMed ID: 22722711
[TBL] [Abstract][Full Text] [Related]
8. Xenotransplantation of interferon-gamma-pretreated clumps of a human mesenchymal stem cell/extracellular matrix complex induces mouse calvarial bone regeneration.
Takeshita K; Motoike S; Kajiya M; Komatsu N; Takewaki M; Ouhara K; Iwata T; Takeda K; Mizuno N; Fujita T; Kurihara H
Stem Cell Res Ther; 2017 Apr; 8(1):101. PubMed ID: 28446226
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stem cells protect from acute liver injury by attenuating hepatotoxicity of liver natural killer T cells in an inducible nitric oxide synthase- and indoleamine 2,3-dioxygenase-dependent manner.
Gazdic M; Simovic Markovic B; Vucicevic L; Nikolic T; Djonov V; Arsenijevic N; Trajkovic V; Lukic ML; Volarevic V
J Tissue Eng Regen Med; 2018 Feb; 12(2):e1173-e1185. PubMed ID: 28488390
[TBL] [Abstract][Full Text] [Related]
10. IDO-independent suppression of T cell effector function by IFN-γ-licensed human mesenchymal stromal cells.
Chinnadurai R; Copland IB; Patel SR; Galipeau J
J Immunol; 2014 Feb; 192(4):1491-501. PubMed ID: 24403533
[TBL] [Abstract][Full Text] [Related]
11. Preconditioning with interleukin-1 beta and interferon-gamma enhances the efficacy of human umbilical cord blood-derived mesenchymal stem cells-based therapy via enhancing prostaglandin E2 secretion and indoleamine 2,3-dioxygenase activity in dextran sulfate sodium-induced colitis.
Yu Y; Yoo SM; Park HH; Baek SY; Kim YJ; Lee S; Kim YL; Seo KW; Kang KS
J Tissue Eng Regen Med; 2019 Oct; 13(10):1792-1804. PubMed ID: 31293088
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.
Zheng ZH; Li XY; Ding J; Jia JF; Zhu P
Rheumatology (Oxford); 2008 Jan; 47(1):22-30. PubMed ID: 18077486
[TBL] [Abstract][Full Text] [Related]
13. Enhanced Immunosuppression of T Cells by Sustained Presentation of Bioactive Interferon-γ Within Three-Dimensional Mesenchymal Stem Cell Constructs.
Zimmermann JA; Hettiaratchi MH; McDevitt TC
Stem Cells Transl Med; 2017 Jan; 6(1):223-237. PubMed ID: 28170190
[TBL] [Abstract][Full Text] [Related]
14. Immunosuppressive properties of human umbilical cord-derived mesenchymal stem cells: role of B7-H1 and IDO.
Tipnis S; Viswanathan C; Majumdar AS
Immunol Cell Biol; 2010; 88(8):795-806. PubMed ID: 20386557
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic efficacy of human adipose mesenchymal stem cells in Crohn's colon fibrosis is improved by IFN-γ and kynurenic acid priming through indoleamine 2,3-dioxygenase-1 signaling.
Ye Y; Zhang X; Su D; Ren Y; Cheng F; Yao Y; Shi G; Ji Y; Chen S; Shi P; Dai L; Su X; Deng H
Stem Cell Res Ther; 2022 Sep; 13(1):465. PubMed ID: 36076306
[TBL] [Abstract][Full Text] [Related]
16. Soluble mediators from mesenchymal stem cells suppress T cell proliferation by inducing IL-10.
Yang SH; Park MJ; Yoon IH; Kim SY; Hong SH; Shin JY; Nam HY; Kim YH; Kim B; Park CG
Exp Mol Med; 2009 May; 41(5):315-24. PubMed ID: 19307751
[TBL] [Abstract][Full Text] [Related]
17. Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells.
Krampera M; Cosmi L; Angeli R; Pasini A; Liotta F; Andreini A; Santarlasci V; Mazzinghi B; Pizzolo G; Vinante F; Romagnani P; Maggi E; Romagnani S; Annunziato F
Stem Cells; 2006 Feb; 24(2):386-98. PubMed ID: 16123384
[TBL] [Abstract][Full Text] [Related]
18. Immunoregulatory Effects of Mesenchymal Stem Cell-Derived Extracellular Vesicles on T Lymphocytes.
Del Fattore A; Luciano R; Pascucci L; Goffredo BM; Giorda E; Scapaticci M; Fierabracci A; Muraca M
Cell Transplant; 2015; 24(12):2615-27. PubMed ID: 25695896
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cells attenuate acute liver injury by altering ratio between interleukin 17 producing and regulatory natural killer T cells.
Milosavljevic N; Gazdic M; Simovic Markovic B; Arsenijevic A; Nurkovic J; Dolicanin Z; Djonov V; Lukic ML; Volarevic V
Liver Transpl; 2017 Aug; 23(8):1040-1050. PubMed ID: 28481005
[TBL] [Abstract][Full Text] [Related]
20. TNF-α modulates the immunosuppressive effects of MSCs on dendritic cells and T cells.
Mohammadpour H; Pourfathollah AA; Zarif MN; Tahoori MT
Int Immunopharmacol; 2015 Oct; 28(2):1009-17. PubMed ID: 26303769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
